Pierre Deny, a French actor best known for his role in Netflix’s “Emily in Paris,” died on Monday from ALS-related complications. He was 69.
Deny played Louis de Léon — the CEO of luxury fashion company JVMA and father of Nicolas (Paul Forman), the love interest of Mindy (Ashley Park) — in Season 3 and 4 of the hit series.
https://t.co/d39D8s6MKG
We've resubmitted our BLA to the FDA for our investigational, muscle-targeted treatment for SMA! Our progress reaffirms the promise of myostatin biology as we continue to prioritize scientific advancement & the needs of children & adults living with SMA. https://t.co/sBGmmtvVok
📢 Big news for the SMA community:
The FDA has approved a high-dose SPINRAZA regimen for SMA—another major step forward in care. Developed by @biogen, this milestone builds on decades of MDA-supported research.
Progress keeps moving
🔗 https://t.co/lZKWRgZglo
#SMA#Research
Family caregivers are essential to the neuromuscular community.
Join MDA Advocacy on 3/2 at 12 PM ET for a special MDA Advocacy Institute spotlight on the Credit for Caring Act & Alleviating Barriers for Caregivers Act.
Hear from Capitol Hill + AARP & learn how to take action.
3/3
➡️ Next stop: the U.S. House for final passage.
📣 Take action—contact your Representative and urge them to support this bill:
🔗 https://t.co/Z2sazstfUP
1/3
🚨 BREAKING: The U.S. Senate just passed legislation advancing major priorities for the neuromuscular disease community—including strong NIH & federal medical research funding.
2/3
The bill also supports kids & families by including the Accelerating Kids’ Access to Care Act and reauthorizing the Rare Pediatric Disease Priority Review Voucher program. ✅
What’s on the public policy horizon for 2026? 🏛️
Join us for the #MDA#Advocacy Institute on Jan. 29 at 7 PM ET to learn about our 2026 advocacy agenda & how the #neuromuscular community can add their voices.
Register: https://t.co/dW6uVMuMsV
🚨 NIH funding vote THIS WEEK. Rare disease research is on the line. 🦓
We dropped a breaking news episode of DNA Today (Ep. 378) on what’s at stake.
👉 Senate vote this week so urger your senators to support the NIH with @MDAorg's tool: https://t.co/yJMeQ3l4qV
Caregivers face growing challenges as support systems fall behind. MDA is advocating for solutions, and we need your input. 🏛️✨
🗣️ Share your caregiving experiences:
https://t.co/Auhxu6Kok3
#Caregiving#MDA#Advocacy#DisabilityPolicy
(1/3) 🎉 The Muscular Dystrophy Association announces the 2026 MDA Legacy Award recipients: Dr. Michio Hirano (Columbia University Irving Medical Center) for lifetime clinical research achievement, and Allison Moore (HNF) for transformative community impact.
(2/3) These leaders will be celebrated at the MDA Clinical and Scientific Conference in Orlando this March. 🧬👏
➡️ Read the full press release to learn more about their groundbreaking work and lasting legacy:
https://t.co/kVzxAQyqyF
➡️ Register Today: https://t.co/rY71BiF2pq
Yesterday, Solid Biosciences shared an important update with the Friedreich’s ataxia community. The first participant has been dosed in the Phase 1b FALCON trial evaluating SGT-212, our novel, investigational dual-route administration gene therapy for the treatment of FA.
We are deeply grateful to the FA community, @CureFA_org, our clinical partners, and the patients and families whose trust and participation make this work possible. Your partnership continues to guide our mission to advance meaningful therapies for people living with FA. Read the full community letter here: https://t.co/11Uc5AyKQJ
#FriedreichsAtaxia #FACommunity #RareDiseaseResearch
You may know me from Grey’s Anatomy as Joe the bartender — or from appearances on Modern Family, You, Chicago Fire, or some other appearance.
I would like to share something important with you about my life and my career.
🧵👇
Amyotrophic lateral sclerosis is a progressive neurodegenerative disease. Here's what you need to know about ALS, from risk factors to new treatments, medications, and clinical trials. https://t.co/dwurjR1tQS